Mohamed Allali
About Mohamed Allali
Mohamed Allali is the Responsable Scientifique Immuno Oncologie at Bristol-Myers Squibb, with extensive experience in the pharmaceutical industry, including roles at Boehringer Ingelheim and AstraZeneca.
Title
Mohamed Allali is currently the Responsable Scientifique Immuno Oncologie at Bristol-Myers Squibb. He has extensive experience in immuno-oncology and the pharmaceutical industry.
Current Position at Bristol-Myers Squibb
Mohamed Allali holds the position of Responsable Scientifique Immuno Oncologie at Bristol-Myers Squibb. His role focuses on the scientific and managerial aspects of immuno-oncology, bringing his expertise to one of the leading pharmaceutical companies known for its pioneering work in cancer treatments since May 2017.
Previous Experience at Boehringer Ingelheim
Mohamed Allali worked at Boehringer Ingelheim in two key roles. From 2014 to 2016, he was the Executive Master Strategy and Management of Health Industries in Ingelheim, Rheinland-Pfalz, Germany. Before that, he served as the Délégué Médical Hospitalier from 2009 to 2014 in Paris, Île-de-France, France. These roles allowed him to develop and implement strategic initiatives in the healthcare sector.
Experience at AstraZeneca
From 2004 to 2009, Mohamed Allali held the position of Délégué Médical at AstraZeneca in Paris, Île-de-France, France. In this role, he was responsible for medical delegations and strengthened his skills in liaising with hospitals and healthcare professionals.
Education and Expertise
Mohamed Allali studied at ESSEC | CentraleSupélec where he earned a Master's degree in Data Sciences & Business Analytics from 2014 to 2015. His educational background supports his analytical skills and business acumen, which are critical for his roles in the health industries.